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Innovative methods for exploring new 
drug-related trends: the EMCDDA 
Trendspotter methodology
I Objective
What is a Trendspotter study?
A Trendspotter study is a rapid information 
assessment that uses multiple social research 
methods to explore a topic of interest or concern. 
The approach was developed and has been used by 
the EMCDDA since 2011 as a tool to complement 
other routine drug monitoring methodologies. It 
has generally been utilised to explore emerging 
phenomena and new trends that are in their infancy 
and/or not covered by existing data sets. 
The goal is to map and describe a new drug trend or 
an emerging phenomenon and identify implications 
for the future. Results can be used to inform 
appropriate and effective decision-making and the 
timely development of practical public health and 
law enforcement responses.
High-risk drug use and new  
psychoactive drugs (2016)
• The problem use of NPS in Europe  
 is currently linked with relatively   
 small numbers of users but high   
 associated levels of harm.
• Use of synthetic cathinones by opioid injectors and   
 among slammers, new trends in synthetic      
 cannabinoids use among prisoners plus       
 developments among marginalised communities.
• Particular public health concerns regarding users of   
 highly potent new synthetic opioids.
Recent changes in Europe’s MDMA/ecstasy 
market (2016)
• Higher-dose MDMA tablets     
 currently appear to be      
 available  in many EU countries.
• Decentralised, more       
 sophisticated and innovative    
       models for production and     
       supply.
• Overdose is probably one of the greatest threats,    
 with high variability of MDMA content in similar    
 looking products.
• Clear central role for the internet in expanding     
 consumer reach and targeting differential consumer   
 risk behaviours
The internet and drug markets (2015)
• Changes in technology and     
 globalisation, as well as a reaction   
 against law enforcement and    
 regulation
• Decentralising of market      
   structures and activities has    
 increased the availability of products, presenting    
 new challenges for law enforcement
• Social media and online communities potentially offer 
 new ways to access help and information
• Online drug marketplaces present methodological   
 questions alongside new ethical considerations for   
 research and monitoring.
 
Who is it for?
There are a range of stakeholders who can benefit 
from using this approach to explore trends and 
developments at the country level for new topics 
where routine data is lacking. These may include 
national drug observatories, research groups, 
community organisations, governmental agencies, 
professionals and policymakers.
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FIGURE 2 | Trendspotter methods
Core methods Optional methods
Literature and data review
Online expert survey
Expert presentations
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Internet snapshot
Additional electronic surveys
Social media
Commission new analysis
FIGURE 1 | Trendspotter characteristics
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I Methods and tools
Most of the individual methods used when 
implementing a trendspotter study are commonly 
found in the social sciences. What it is specific to 
this approach is the way the combination of these 
methods is processed. For each study, a core set 
of methods are required, and additional methods 
may be included when appropriate. Importantly, 
the mixed method approach used is underpinned 
by triangulation of sources in order to enhance the 
reliability and validity of findings (Figure 2).
I Study process 
The study process involves a number of consecutive 
but overlapping phases, moving through planning 
data gathering, analysis and reporting tasks. 
Importantly, the data gathering and analysis takes 
place in two rounds. The first round involves the use 
of both qualitative and quantitative methods by the 
team and concludes with a preliminary analysis 
of results. The second round of data gathering 
takes place at a structured expert meeting, and 
functions mainly to gather expert opinion as well as 
to use experts to enhance and fine tune the study’s 
analysis and results.
I Outputs
The study concludes with the production of a 
concise report presenting the main findings of 
the analysis. The results need to be timely, and 
disseminated rapidly in order to feed into other 
formal reporting mechanisms, e.g. national reports, 
and policy and planning tools.
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I Recent EMCDDA  
   Trendspotter studies
DIMS reports of MDMA tablet content levels in the Netherlands, 2003–15
Source: DIMS, 2015.
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